Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
06/05/2001 | US6241662 Acetic acid as a signal enhancing contrast agent in fluorescence spectroscopy |
06/05/2001 | US6240839 Device for proofing dough |
06/05/2001 | US6240766 Method and apparatus for assessing the ripeness or firmness of fruit and vegetables |
06/05/2001 | CA2155185C Totally synthetic affinity reagents |
06/05/2001 | CA2130028C Method for determining sugar chain structure |
06/05/2001 | CA2112408C Monoclonal antibody to lymphocyte-associated cell surface protein |
06/05/2001 | CA2030757C Agent for the storage and suspension of cells, especially erythrocytes |
06/05/2001 | CA1341241C Expression of a tumor-specific antigen through a recombinant virus vector, and its use for prevention or cure of the corresponding tumor |
06/04/2001 | WO2001042474A2 Interferon-like molecules and uses thereof |
06/04/2001 | CA2395408A1 Interferon-like molecules and uses thereof |
06/03/2001 | CA2327305A1 Microdroplet dispensing for a medical diagnostic device |
06/03/2001 | CA2325806A1 Methods for the diagnosis and prognosis of acute leukemias |
06/01/2001 | CA2315555A1 Ozone sensor and method for use of same in water purification system |
05/31/2001 | WO2001038880A1 A method for the determination of transmissible spongiform encephalopathies in mammals |
05/31/2001 | WO2001038879A2 Method, apparatus, media and signals for identifying associated cell signaling proteins |
05/31/2001 | WO2001038878A2 Pin1 as a marker for abnormal cell growth |
05/31/2001 | WO2001038877A2 Multiblot kinase analysis |
05/31/2001 | WO2001038876A1 Sandwich immunoassay and monoclonal antibodies for comp, cartillage oligomeric matrix protein |
05/31/2001 | WO2001038875A1 Biochip reader and labeling reagent |
05/31/2001 | WO2001038874A1 Expression cloning method |
05/31/2001 | WO2001038873A2 Devices and methods for detecting analytes using electrosensor having capture reagent |
05/31/2001 | WO2001038872A2 Assay of isomerised and/or optically inverted proteins |
05/31/2001 | WO2001038871A1 A method of diagnosing or prognosticating hiv infection in a subject |
05/31/2001 | WO2001038870A1 Method of detecting gynecological carcinomas |
05/31/2001 | WO2001038869A2 System for determination of wastewater biodegradability |
05/31/2001 | WO2001038868A1 Standard sample composition and manufacture thereof |
05/31/2001 | WO2001038862A1 Cholesterol sensor and method for determining cholesterol |
05/31/2001 | WO2001038854A1 Pyros kinetix reader for conducting assays |
05/31/2001 | WO2001038852A1 Quantitative detection of viruses by light scattering |
05/31/2001 | WO2001038850A2 Intrinsic dissolution apparatus with stationary sample holder |
05/31/2001 | WO2001038849A1 Method and machine for grading timber elements |
05/31/2001 | WO2001038846A1 Sampling device |
05/31/2001 | WO2001038845A2 Apparatus and methods for identifying ligands |
05/31/2001 | WO2001038587A2 Energy-transfer assay for polynucleic acid polymerases |
05/31/2001 | WO2001038584A2 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
05/31/2001 | WO2001038583A2 Capillary array-based sample screening |
05/31/2001 | WO2001038580A2 Nucleic acid probe arrays |
05/31/2001 | WO2001038571A1 Mismatch-recognizing molecules |
05/31/2001 | WO2001038570A1 Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample |
05/31/2001 | WO2001038568A2 Automated method for identifying related biomolecular sequences |
05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
05/31/2001 | WO2001038564A2 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy |
05/31/2001 | WO2001038560A2 Active enzyme detection using immobilized enzyme inhibitors |
05/31/2001 | WO2001038557A1 Method of screening multiply transformed cells using bicistronic expression of fluorescent proteins |
05/31/2001 | WO2001038538A1 Polymerase compositions and methods of use thereof |
05/31/2001 | WO2001038532A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
05/31/2001 | WO2001038527A1 Novel protein tab2 |
05/31/2001 | WO2001038526A1 Human tnf receptor |
05/31/2001 | WO2001038486A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
05/31/2001 | WO2001038482A1 Hybridization device, case, support, and label agent |
05/31/2001 | WO2001038396A1 Collagen |
05/31/2001 | WO2001038393A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
05/31/2001 | WO2001038392A1 Novel transcription factor and dna thereof |
05/31/2001 | WO2001038354A1 Method of separating prions from biological materials |
05/31/2001 | WO2001038352A2 Methods of inhibiting metastasis |
05/31/2001 | WO2001038348A2 G-protein coupled receptor htogh35 |
05/31/2001 | WO2001038344A2 Modulation of signal transduction |
05/31/2001 | WO2001038268A1 Apparatus and method for synthesizing combinatorial libraries |
05/31/2001 | WO2001037870A1 Treatment of autoimmune diseases by an agonistic cd40-binding protein |
05/31/2001 | WO2001037866A1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
05/31/2001 | WO2001037865A1 Compositions and methods for treatment of allergic disorders |
05/31/2001 | WO2001037864A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
05/31/2001 | WO2001037852A2 Methods of inhibiting atrophy or promoting hypertrophy |
05/31/2001 | WO2001037850A2 Use of a milk protein hydrolysate in the treatment of diabetes |
05/31/2001 | WO2001037719A2 Prognostic testing of organs intended for transplantation |
05/31/2001 | WO2001031346A8 Identification of novel pro- and anti-angiogenic agents |
05/31/2001 | WO2001023875A3 METHOD FOR DIAGNOSING THE LEVEL OF DETERIORATION OF AN NOx CATALYST LOCATED IN THE EXHAUST CHANNEL OF AN INTERNAL COMBUSTION ENGINE |
05/31/2001 | WO2001014864A3 A gas sensor and its method of manufacture |
05/31/2001 | WO2001007889A3 Miniaturized cell array methods and apparatus for cell-based screening |
05/31/2001 | WO2001002598A3 Screening for compounds modulating mitochondrial proton leak |
05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |
05/31/2001 | WO2000073493A3 A nematode drug screen for modulators of mammalian disorders |
05/31/2001 | WO2000073491A3 Novel method for investigating the suitability of a material as a medicament |
05/31/2001 | WO2000072880A3 Prevention and treatment of amyloidogenic disease |
05/31/2001 | WO2000072652A3 Method for imaging logs or stems and apparatus |
05/31/2001 | WO2000072258A3 Method and system for general purpose analysis of experimental data |
05/31/2001 | WO2000071748A3 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants |
05/31/2001 | WO2000066708A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
05/31/2001 | WO2000061754A3 Human proteins and polynucleotides encoding them |
05/31/2001 | WO2000060332A3 Self-encoding sensor with microspheres |
05/31/2001 | WO2000059729A3 Wide format thermal printing apparatus including an ink donor sheet assembly with a memory |
05/31/2001 | WO2000056901A3 Linear and circular expression elements |
05/31/2001 | WO2000042165A3 Bone marrow-specific protein |
05/31/2001 | WO2000042071A3 Compounds and methods to inhibit or augment an inflammatory response |
05/31/2001 | WO2000032196A3 Inhibitors of multidrug transporters |
05/31/2001 | WO2000017327A3 Terpene synthases |
05/31/2001 | WO2000016101A3 Target analyte sensors utilizing microspheres |
05/31/2001 | WO2000014530A8 Azo dye aqueous solution, preparation method and use |
05/31/2001 | WO2000012735A3 Transgene assay using stable agrobacterium rhizogenes transformation |
05/31/2001 | WO2000006712A3 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
05/31/2001 | WO1999035255A9 Compositions and methods for regulated secretion from neuroendocrine cell lines |
05/31/2001 | WO1999024394A9 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
05/31/2001 | WO1998059243A8 High density streptavidin supports |
05/31/2001 | WO1998032014A8 Basophil degranulation test |
05/31/2001 | US20010002393 Administering to a patient suffering from leiomyoma (fibroid)of uterus an effective dose of an agent which specifically inhibit metalloproteinase selected from stromelysin-2, stromelysin-3 and matrilysin |
05/31/2001 | US20010002316 Light scatter-based immunoassay |
05/31/2001 | US20010002315 Plasmon resonant particles, methods and apparatus |
05/31/2001 | DE19958309A1 Differential diagnosis of varicoses, useful for distinguishing between primary and pelvigenic varices, comprises differences in estrogen content between varicose and control blood samples |